Long-Term P2Y 12 Inhibitor or Aspirin as Single Antiplatelet Therapy in Patients With Previous Percutaneous Coronary Intervention.
Davide CapodannoDominick J AngiolilloPublished in: Circulation (2023)
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- acute myocardial infarction
- st elevation myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- coronary artery bypass
- atrial fibrillation
- low dose
- heart failure
- cardiovascular disease
- type diabetes